{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:23:40Z","timestamp":1766755420252,"version":"3.48.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-025-01444-z","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T07:37:42Z","timestamp":1762328262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Osteoprotective Effects of Melatonin on Bone Loss Associated with Dopaminergic Neuron Degeneration in a Rat Model of Parkinson Disease"],"prefix":"10.1007","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1798-3459","authenticated-orcid":false,"given":"Latifa","family":"Knani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajer","family":"Rouis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaouthar","family":"Kessabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imed","family":"Messaoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"1444_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.apmr.2020.04.001","volume":"102","author":"J Lo","year":"2021","unstructured":"Lo J, Chan L, Flynn S (2021) A systematic review of the incidence, prevalence, costs, and activity and work limitations of amputation, osteoarthritis, rheumatoid arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and traumatic brain injury in the United States: a 2019 update. Arch Phys Med Rehabil 102:115\u2013131. https:\/\/doi.org\/10.1016\/j.apmr.2020.04.001","journal-title":"Arch Phys Med Rehabil"},{"key":"1444_CR2","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/art.42089","volume":"74","author":"H Long","year":"2022","unstructured":"Long H, Liu Q, Yin H et al (2022) Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019. Arthritis Rheumatol 74:1172\u20131183. https:\/\/doi.org\/10.1002\/art.42089","journal-title":"Arthritis Rheumatol"},{"key":"1444_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1359\/jbmr.1997.12.1.24","volume":"12","author":"NF Ray","year":"1997","unstructured":"Ray NF, Chan JK, Thamer M, Melton LJ (1997) Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 12:24\u201335. https:\/\/doi.org\/10.1359\/jbmr.1997.12.1.24","journal-title":"J Bone Miner Res"},{"key":"1444_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.110668","volume":"132","author":"L Chakuleska","year":"2019","unstructured":"Chakuleska L, Michailova R, Shkondrov A et al (2019) Bone protective effects of purified extract from Ruscus aculeatus on ovariectomy-induced osteoporosis in rats. Food Chem Toxicol 132:110668. https:\/\/doi.org\/10.1016\/j.fct.2019.110668","journal-title":"Food Chem Toxicol"},{"key":"1444_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/qjmed\/hcv012","volume":"108","author":"S-J Chen","year":"2015","unstructured":"Chen S-J, Liao W-C, Huang K-H et al (2015) Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study. QJM 108:633\u2013640. https:\/\/doi.org\/10.1093\/qjmed\/hcv012","journal-title":"QJM"},{"key":"1444_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00198-015-3386-5","volume":"27","author":"CM Weaver","year":"2016","unstructured":"Weaver CM, Alexander DD, Boushey CJ et al (2016) Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int 27:367\u2013376. https:\/\/doi.org\/10.1007\/s00198-015-3386-5","journal-title":"Osteoporos Int"},{"key":"1444_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108650","volume":"112","author":"H Xu","year":"2019","unstructured":"Xu H, Liu T, Hu L et al (2019) Effect of caffeine on ovariectomy-induced osteoporosis in rats. Biomed Pharmacother 112:108650. https:\/\/doi.org\/10.1016\/j.biopha.2019.108650","journal-title":"Biomed Pharmacother"},{"key":"1444_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jn\/126.1.161","volume":"126","author":"BH Arjmandi","year":"1996","unstructured":"Arjmandi BH, Alekel L, Hollis BW et al (1996) Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161\u2013167. https:\/\/doi.org\/10.1093\/jn\/126.1.161","journal-title":"J Nutr"},{"key":"1444_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6882-11-10","volume":"11","author":"NK Saleh","year":"2011","unstructured":"Saleh NK, Saleh HA (2011) Olive oil effectively mitigates ovariectomy-induced osteoporosis in rats. BMC Complement Altern Med 11:10. https:\/\/doi.org\/10.1186\/1472-6882-11-10","journal-title":"BMC Complement Altern Med"},{"key":"1444_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22832","volume":"35","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Song X, Chen X et al (2021) Antiosteoporotic effect of hesperidin against ovariectomy-induced osteoporosis in rats via reduction of oxidative stress and inflammation. J Biochem Mol Toxicol 35:e22832. https:\/\/doi.org\/10.1002\/jbt.22832","journal-title":"J Biochem Mol Toxicol"},{"key":"1444_CR11","doi-asserted-by":"publisher","first-page":"1326212","DOI":"10.3389\/fendo.2024.1326212","volume":"15","author":"DP Lima","year":"2024","unstructured":"Lima DP, Chagas-Neto das FA, Gomes de Luna JR et al (2024) Osteoporosis in Parkinson\u2019s disease and the role of lean body mass: a cross-sectional study in a Brazilian tertiary center. Front Endocrinol (Lausanne) 15:1326212. https:\/\/doi.org\/10.3389\/fendo.2024.1326212","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Pt 5","key":"1444_CR12","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain 114(Pt 5):2283\u20132301. https:\/\/doi.org\/10.1093\/brain\/114.5.2283","journal-title":"Brain"},{"key":"1444_CR13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewicz O (1960) Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin Wochenschr 38:1236\u20131239. https:\/\/doi.org\/10.1007\/BF01485901","journal-title":"Klin Wochenschr"},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/ijms21072464","volume":"21","author":"SJ Chia","year":"2020","unstructured":"Chia SJ, Tan E-K, Chao Y-X (2020) Historical perspective: models of Parkinson\u2019s disease. Int J Mol Sci 21:2464. https:\/\/doi.org\/10.3390\/ijms21072464","journal-title":"Int J Mol Sci"},{"key":"1444_CR15","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","volume":"101","author":"MM McGregor","year":"2019","unstructured":"McGregor MM, Nelson AB (2019) Circuit mechanisms of Parkinson\u2019s disease. Neuron 101:1042\u20131056. https:\/\/doi.org\/10.1016\/j.neuron.2019.03.004","journal-title":"Neuron"},{"key":"1444_CR16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ana.10577","volume":"53","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hern\u00e1n MA et al (2003) Weight loss in Parkinson\u2019s disease. Ann Neurol 53:676\u2013679. https:\/\/doi.org\/10.1002\/ana.10577","journal-title":"Ann Neurol"},{"key":"1444_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/17446651.2020.1756772","volume":"15","author":"CA Figueroa","year":"2020","unstructured":"Figueroa CA, Rosen CJ (2020) Parkinson\u2019s disease and osteoporosis: basic and clinical implications. Expert Rev Endocrinol Metab 15:185\u2013193. https:\/\/doi.org\/10.1080\/17446651.2020.1756772","journal-title":"Expert Rev Endocrinol Metab"},{"key":"1444_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2024.117271","volume":"190","author":"L Knani","year":"2025","unstructured":"Knani L, Venditti M, Rouis H et al (2025) Effects of dopaminergic neuron degeneration on osteocyte apoptosis and osteogenic markers in 6-OHDA male rat model of Parkinson\u2019s disease. Bone 190:117271. https:\/\/doi.org\/10.1016\/j.bone.2024.117271","journal-title":"Bone"},{"key":"1444_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/antiox10020210","volume":"10","author":"M-A Bonmati-Carrion","year":"2021","unstructured":"Bonmati-Carrion M-A, Tomas-Loba A (2021) Melatonin and cancer: a polyhedral network where the source matters. Antioxidants (Basel) 10:210. https:\/\/doi.org\/10.3390\/antiox10020210","journal-title":"Antioxidants (Basel)"},{"key":"1444_CR20","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1111\/j.1742-4658.2006.05322.x","volume":"273","author":"SR Pandi-Perumal","year":"2006","unstructured":"Pandi-Perumal SR, Srinivasan V, Maestroni GJM et al (2006) Melatonin: nature\u2019s most versatile biological signal? FEBS J 273:2813\u20132838. https:\/\/doi.org\/10.1111\/j.1742-4658.2006.05322.x","journal-title":"FEBS J"},{"key":"1444_CR21","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1210\/er.2018-00084","volume":"39","author":"J Cipolla-Neto","year":"2018","unstructured":"Cipolla-Neto J, Amaral FG (2018) Melatonin as a hormone: new physiological and clinical insights. Endocr Rev 39:990\u20131028. https:\/\/doi.org\/10.1210\/er.2018-00084","journal-title":"Endocr Rev"},{"key":"1444_CR22","doi-asserted-by":"publisher","first-page":"e12465","DOI":"10.1111\/jpi.12465","volume":"64","author":"S Maria","year":"2018","unstructured":"Maria S, Samsonraj RM, Munmun F et al (2018) Biological effects of melatonin on osteoblast\/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1\/2, and MEK5 in melatonin-mediated osteoblastogenesis. J Pineal Res 64:e12465. https:\/\/doi.org\/10.1111\/jpi.12465","journal-title":"J Pineal Res"},{"key":"1444_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1600-079X.2012.01007.x","volume":"53","author":"PA Witt-Enderby","year":"2012","unstructured":"Witt-Enderby PA, Slater JP, Johnson NA et al (2012) Effects on bone by the light\/dark cycle and chronic treatment with melatonin and\/or hormone replacement therapy in intact female mice. J Pineal Res 53:374\u2013384. https:\/\/doi.org\/10.1111\/j.1600-079X.2012.01007.x","journal-title":"J Pineal Res"},{"key":"1444_CR24","doi-asserted-by":"publisher","first-page":"10063","DOI":"10.3390\/ijms140510063","volume":"14","author":"J Liu","year":"2013","unstructured":"Liu J, Huang F, He H-W (2013) Melatonin effects on hard tissues: bone and tooth. Int J Mol Sci 14:10063\u201310074. https:\/\/doi.org\/10.3390\/ijms140510063","journal-title":"Int J Mol Sci"},{"key":"1444_CR25","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqab057","volume":"162","author":"J-H Choi","year":"2021","unstructured":"Choi J-H, Jang A-R, Park M-J et al (2021) Melatonin inhibits osteoclastogenesis and bone loss in ovariectomized mice by regulating PRMT1-mediated signaling. Endocrinology 162:bqab057. https:\/\/doi.org\/10.1210\/endocr\/bqab057","journal-title":"Endocrinology"},{"key":"1444_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/jpi.12252","volume":"59","author":"AK Amstrup","year":"2015","unstructured":"Amstrup AK, Sikjaer T, Heickendorff L et al (2015) Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: a randomized controlled trial. J Pineal Res 59:221\u2013229. https:\/\/doi.org\/10.1111\/jpi.12252","journal-title":"J Pineal Res"},{"key":"1444_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12937-015-0093-1","volume":"14","author":"AK Amstrup","year":"2015","unstructured":"Amstrup AK, Sikjaer T, Mosekilde L, Rejnmark L (2015) The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr J 14:102. https:\/\/doi.org\/10.1186\/s12937-015-0093-1","journal-title":"Nutr J"},{"key":"1444_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197174","volume":"21","author":"F Luo","year":"2020","unstructured":"Luo F, Sandhu AF, Rungratanawanich W et al (2020) Melatonin and autophagy in aging-related neurodegenerative diseases. Int J Mol Sci 21:7174. https:\/\/doi.org\/10.3390\/ijms21197174","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1444_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1096\/fj.00-0129com","volume":"15","author":"FE Dabbeni-Sala","year":"2001","unstructured":"Dabbeni-Sala FE, Di Santo ST, Franceschini D, Skaper St D, Pietro Giusti AN (2001) Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J 15(1):164\u2013170","journal-title":"FASEB J"},{"key":"1444_CR30","doi-asserted-by":"publisher","DOI":"10.5402\/2012\/360379","volume":"2012","author":"AL Gutierrez-Valdez","year":"2012","unstructured":"Gutierrez-Valdez AL, Anaya-Mart\u00ednez V, Ordo\u00f1ez-Librado JL et al (2012) Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis. ISRN Neurol 2012:360379. https:\/\/doi.org\/10.5402\/2012\/360379","journal-title":"ISRN Neurol"},{"key":"1444_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/s0024-3205(01)01480-1","volume":"70","author":"LMV Aguiar","year":"2002","unstructured":"Aguiar LMV, Vasconcelos SMM, Sousa FCF, Viana GSB (2002) Melatonin reverses neurochemical alterations induced by 6-OHDA in rat striatum. Life Sci 70:1041\u20131051. https:\/\/doi.org\/10.1016\/s0024-3205(01)01480-1","journal-title":"Life Sci"},{"key":"1444_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.brainres.2005.10.084","volume":"1068","author":"R Sharma","year":"2006","unstructured":"Sharma R, McMillan CR, Tenn CC, Niles LP (2006) Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson\u2019s disease. Brain Res 1068:230\u2013236. https:\/\/doi.org\/10.1016\/j.brainres.2005.10.084","journal-title":"Brain Res"},{"key":"1444_CR33","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/s1734-1140(13)71479-8","volume":"65","author":"SA Zaitone","year":"2013","unstructured":"Zaitone SA, Hammad LN, Farag NE (2013) Antioxidant potential of melatonin enhances the response to L-dopa in 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-parkinsonian mice. Pharmacol Rep 65:1213\u20131226. https:\/\/doi.org\/10.1016\/s1734-1140(13)71479-8","journal-title":"Pharmacol Rep"},{"key":"1444_CR34","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","volume":"254","author":"CAM Medeiros","year":"2007","unstructured":"Medeiros CAM, Carvalhedo de Bruin PF, Lopes LA et al (2007) Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson\u2019s disease. A randomized, double blind, placebo-controlled study. J Neurol 254:459\u2013464. https:\/\/doi.org\/10.1007\/s00415-006-0390-x","journal-title":"J Neurol"},{"key":"1444_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neuro.2021.11.011","volume":"88","author":"S Yildirim","year":"2022","unstructured":"Yildirim S, Ozkan A, Aytac G et al (2022) Role of melatonin in TLR4-mediated inflammatory pathway in the MTPT-induced mouse model. Neurotoxicology 88:168\u2013177. https:\/\/doi.org\/10.1016\/j.neuro.2021.11.011","journal-title":"Neurotoxicology"},{"key":"1444_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brainres.2014.09.068","volume":"1593","author":"TB Bassani","year":"2014","unstructured":"Bassani TB, Gradowski RW, Zaminelli T et al (2014) Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson\u2019s disease model in rats. Brain Res 1593:95\u2013105. https:\/\/doi.org\/10.1016\/j.brainres.2014.09.068","journal-title":"Brain Res"},{"key":"1444_CR37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41398-023-02614-z","volume":"13","author":"D Yao","year":"2023","unstructured":"Yao D, Li R, Hao J et al (2023) Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization. Transl Psychiatry 13:310. https:\/\/doi.org\/10.1038\/s41398-023-02614-z","journal-title":"Transl Psychiatry"},{"key":"1444_CR38","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12031-020-01760-z","volume":"71","author":"L Tancheva","year":"2021","unstructured":"Tancheva L, Lazarova M, Saso L et al (2021) Beneficial effect of melatonin on motor and memory disturbances in 6-OHDA-lesioned rats. J Mol Neurosci 71:702\u2013712. https:\/\/doi.org\/10.1007\/s12031-020-01760-z","journal-title":"J Mol Neurosci"},{"key":"1444_CR39","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1177\/0748730407308167","volume":"22","author":"PA Bartell","year":"2007","unstructured":"Bartell PA, Miranda-Anaya M, McIvor W, Menaker M (2007) Interactions between dopamine and melatonin organize circadian rhythmicity in the retina of the green iguana. J Biol Rhythms 22:515\u2013523. https:\/\/doi.org\/10.1177\/0748730407308167","journal-title":"J Biol Rhythms"},{"key":"1444_CR40","unstructured":"George P, Charles W (2008) The rat brain in stereotaxic coordinates: compact"},{"key":"1444_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1385\/JMN:14:3:147","volume":"14","author":"JC Garc\u00eda","year":"2000","unstructured":"Garc\u00eda JC, Remires D, Leiva A, Gonz\u00e1lez R (2000) Depletion of brain glutathione potentiates the effect of 6-hydroxydopamine in a rat model of Parkinson\u2019s disease. J Mol Neurosci 14:147\u2013153. https:\/\/doi.org\/10.1385\/JMN:14:3:147","journal-title":"J Mol Neurosci"},{"key":"1444_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.650597","volume":"12","author":"S P\u00e9rez-Lloret","year":"2021","unstructured":"P\u00e9rez-Lloret S, Cardinali DP (2021) Melatonin as a chronobiotic and cytoprotective agent in Parkinson\u2019s disease. Front Pharmacol 12:650597. https:\/\/doi.org\/10.3389\/fphar.2021.650597","journal-title":"Front Pharmacol"},{"key":"1444_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12931","volume":"76","author":"DP Cardinali","year":"2024","unstructured":"Cardinali DP (2024) Melatonin as a chronobiotic\/cytoprotective agent in bone. Doses involved. J Pineal Res 76:e12931. https:\/\/doi.org\/10.1111\/jpi.12931","journal-title":"J Pineal Res"},{"key":"1444_CR44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/s0301-0082(96)00015-9","volume":"49","author":"RK Schwarting","year":"1996","unstructured":"Schwarting RK, Huston JP (1996) Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 49:215\u2013266. https:\/\/doi.org\/10.1016\/s0301-0082(96)00015-9","journal-title":"Prog Neurobiol"},{"key":"1444_CR45","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1523\/JNEUROSCI.14-06-03449.1994","volume":"14","author":"G Nikkhah","year":"1994","unstructured":"Nikkhah G, Bentlage C, Cunningham MG, Bj\u00f6rklund A (1994) Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J Neurosci 14:3449\u20133461. https:\/\/doi.org\/10.1523\/JNEUROSCI.14-06-03449.1994","journal-title":"J Neurosci"},{"key":"1444_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","volume":"24","author":"U Ungerstedt","year":"1970","unstructured":"Ungerstedt U, Arbuthnott GW (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24:485\u2013493. https:\/\/doi.org\/10.1016\/0006-8993(70)90187-3","journal-title":"Brain Res"},{"key":"1444_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0006-8993(87)90885-7","volume":"426","author":"RM Shapiro","year":"1987","unstructured":"Shapiro RM, Glick SD, Camarota NA (1987) A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation. Brain Res 426:323\u2013331. https:\/\/doi.org\/10.1016\/0006-8993(87)90885-7","journal-title":"Brain Res"},{"key":"1444_CR48","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","volume":"189","author":"H Shiotsuki","year":"2010","unstructured":"Shiotsuki H, Yoshimi K, Shimo Y et al (2010) A rotarod test for evaluation of motor skill learning. J Neurosci Methods 189:180\u2013185. https:\/\/doi.org\/10.1016\/j.jneumeth.2010.03.026","journal-title":"J Neurosci Methods"},{"key":"1444_CR49","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/s0028-3908(00)00005-8","volume":"39","author":"T Schallert","year":"2000","unstructured":"Schallert T, Fleming SM, Leasure JL et al (2000) CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39:777\u2013787. https:\/\/doi.org\/10.1016\/s0028-3908(00)00005-8","journal-title":"Neuropharmacology"},{"key":"1444_CR50","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bbi.2018.02.004","volume":"69","author":"W Zhu","year":"2018","unstructured":"Zhu W, Gao Y, Wan J et al (2018) Changes in motor function, cognition, and emotion-related behavior after right hemispheric intracerebral hemorrhage in various brain regions of mouse. Brain Behav Immun 69:568\u2013581. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.004","journal-title":"Brain Behav Immun"},{"key":"1444_CR51","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbr.2015.01.053","volume":"284","author":"J Boix","year":"2015","unstructured":"Boix J, Padel T, Paul G (2015) A partial lesion model of Parkinson\u2019s disease in mice\u2013characterization of a 6-OHDA-induced medial forebrain bundle lesion. Behav Brain Res 284:196\u2013206. https:\/\/doi.org\/10.1016\/j.bbr.2015.01.053","journal-title":"Behav Brain Res"},{"key":"1444_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"S Marklund","year":"1974","unstructured":"Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469\u2013474. https:\/\/doi.org\/10.1111\/j.1432-1033.1974.tb03714.x","journal-title":"Eur J Biochem"},{"key":"1444_CR53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4236\/abb.2010.11006","volume":"01","author":"S Sahu","year":"2010","unstructured":"Sahu S, Das P, Ray M, Sabat SC (2010) Osmolyte modulated enhanced rice leaf catalase activity under salt-stress. ABB 01:39\u201346. https:\/\/doi.org\/10.4236\/abb.2010.11006","journal-title":"ABB"},{"key":"1444_CR54","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/s0076-6879(78)52032-6","volume":"52","author":"JA Buege","year":"1978","unstructured":"Buege JA, Aust SD (1978) Microsomal lipid peroxidation. Methods Enzymol 52:302\u2013310. https:\/\/doi.org\/10.1016\/s0076-6879(78)52032-6","journal-title":"Methods Enzymol"},{"key":"1444_CR55","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","volume":"25","author":"J Sedlak","year":"1968","unstructured":"Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman\u2019s reagent. Anal Biochem 25:192\u2013205. https:\/\/doi.org\/10.1016\/0003-2697(68)90092-4","journal-title":"Anal Biochem"},{"key":"1444_CR56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254. https:\/\/doi.org\/10.1016\/0003-2697(76)90527-3","journal-title":"Anal Biochem"},{"key":"1444_CR57","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.bone.2003.12.012","volume":"34","author":"H Follet","year":"2004","unstructured":"Follet H, Boivin G, Rumelhart C, Meunier PJ (2004) The degree of mineralization is a determinant of bone strength: a study on human calcanei. Bone 34:783\u2013789. https:\/\/doi.org\/10.1016\/j.bone.2003.12.012","journal-title":"Bone"},{"key":"1444_CR58","first-page":"525","volume":"93","author":"R Socha","year":"2013","unstructured":"Socha R, Nemec V (2013) Coloration and pteridine pattern in a new, yolk body mutant of Pyrrhocoris apterus (Heteroptera: Pyrrhocoridae). EJE 93:525\u2013534","journal-title":"EJE"},{"key":"1444_CR59","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/cen.12538","volume":"81","author":"SM Abdalla","year":"2014","unstructured":"Abdalla SM, Bianco AC (2014) Defending plasma T3 is a biological priority. Clin Endocrinol (Oxf) 81:633\u2013641. https:\/\/doi.org\/10.1111\/cen.12538","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1444_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36:1\u201312. https:\/\/doi.org\/10.1016\/j.cger.2019.08.002","journal-title":"Clin Geriatr Med"},{"key":"1444_CR61","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s00774-022-01322-w","volume":"40","author":"T-L Kim","year":"2022","unstructured":"Kim T-L, Byun SJ, Seong MY et al (2022) Fracture risk and impact of osteoporosis in patients with Parkinson\u2019s disease: a nationwide database study. J Bone Miner Metab 40:602\u2013612. https:\/\/doi.org\/10.1007\/s00774-022-01322-w","journal-title":"J Bone Miner Metab"},{"key":"1444_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2024.108181","volume":"239","author":"F Zhang","year":"2024","unstructured":"Zhang F, Lu J, Zhang Y, Liu J (2024) Significance of non-motor symptoms and development of a screening tool for osteoporosis in Parkinson\u2019s disease. Clin Neurol Neurosurg 239:108181. https:\/\/doi.org\/10.1016\/j.clineuro.2024.108181","journal-title":"Clin Neurol Neurosurg"},{"key":"1444_CR63","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009316","volume":"1","author":"K Tieu","year":"2011","unstructured":"Tieu K (2011) A guide to neurotoxic animal models of Parkinson\u2019s disease. Cold Spring Harb Perspect Med 1:a009316. https:\/\/doi.org\/10.1101\/cshperspect.a009316","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1444_CR64","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","volume":"12","author":"A Dovonou","year":"2023","unstructured":"Dovonou A, Bolduc C, Soto Linan V et al (2023) Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions. Transl Neurodegener 12:36. https:\/\/doi.org\/10.1186\/s40035-023-00368-8","journal-title":"Transl Neurodegener"},{"key":"1444_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106848","volume":"208","author":"T Wichmann","year":"2025","unstructured":"Wichmann T, Nelson A, Torres ERS et al (2025) Leveraging animal models to understand non-motor symptoms of Parkinson\u2019s disease. Neurobiol Dis 208:106848. https:\/\/doi.org\/10.1016\/j.nbd.2025.106848","journal-title":"Neurobiol Dis"},{"key":"1444_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70008","volume":"169","author":"M Prates-Rodrigues","year":"2025","unstructured":"Prates-Rodrigues M, Schweizer BLA, de Paula Gomes C et al (2025) Challenges and opportunities in exploring non-motor symptoms in 6-hydroxydopamine models of Parkinson\u2019s disease: a systematic review. J Neurochem 169:e70008. https:\/\/doi.org\/10.1111\/jnc.70008","journal-title":"J Neurochem"},{"key":"1444_CR67","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0006-8993(93)90925-d","volume":"613","author":"H Jiang","year":"1993","unstructured":"Jiang H, Jackson-Lewis V, Muthane U et al (1993) Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats. Brain Res 613:347\u2013351. https:\/\/doi.org\/10.1016\/0006-8993(93)90925-d","journal-title":"Brain Res"},{"key":"1444_CR68","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/190450","volume":"2010","author":"H Chan","year":"2010","unstructured":"Chan H, Paur H, Vernon AC et al (2010) Neuroprotection and functional recovery associated with decreased microglial activation following selective activation of mGluR2\/3 receptors in a rodent model of Parkinson\u2019s disease. Parkinsons Dis 2010:190450. https:\/\/doi.org\/10.4061\/2010\/190450","journal-title":"Parkinsons Dis"},{"key":"1444_CR69","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.nbd.2011.04.007","volume":"43","author":"E Ilijic","year":"2011","unstructured":"Ilijic E, Guzman JN, Surmeier DJ (2011) The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson\u2019s disease. Neurobiol Dis 43:364\u2013371. https:\/\/doi.org\/10.1016\/j.nbd.2011.04.007","journal-title":"Neurobiol Dis"},{"key":"1444_CR70","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.3390\/ijms25105122","volume":"25","author":"G Bocheva","year":"2024","unstructured":"Bocheva G, Bakalov D, Iliev P, Tafradjiiska-Hadjiolova R (2024) The vital role of melatonin and its metabolites in the neuroprotection and retardation of brain aging. Int J Mol Sci 25:5122. https:\/\/doi.org\/10.3390\/ijms25105122","journal-title":"Int J Mol Sci"},{"key":"1444_CR71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12640-024-00700-8","volume":"42","author":"MY El Brouzi","year":"2024","unstructured":"El Brouzi MY, Lamtai M, Zghari O et al (2024) Melatonin is a neuroprotective and antioxidant agent against neurotoxicity induced by an intrahippocampal injection of nickel in rats. Neurotox Res 42:24. https:\/\/doi.org\/10.1007\/s12640-024-00700-8","journal-title":"Neurotox Res"},{"key":"1444_CR72","doi-asserted-by":"publisher","first-page":"9624","DOI":"10.3390\/cimb46090572","volume":"46","author":"Q Sun","year":"2024","unstructured":"Sun Q, Xu L, Hu Z et al (2024) Melatonin regulates osteoblast differentiation through the m6A reader hnRNPA2B1 under simulated microgravity. Curr Issues Mol Biol 46:9624\u20139638. https:\/\/doi.org\/10.3390\/cimb46090572","journal-title":"Curr Issues Mol Biol"},{"key":"1444_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5577541","volume":"2021","author":"A Jim\u00e9nez-Delgado","year":"2021","unstructured":"Jim\u00e9nez-Delgado A, Ortiz GG, Delgado-Lara DL et al (2021) Effect of melatonin administration on mitochondrial activity and oxidative stress markers in patients with Parkinson\u2019s disease. Oxid Med Cell Longev 2021:5577541. https:\/\/doi.org\/10.1155\/2021\/5577541","journal-title":"Oxid Med Cell Longev"},{"key":"1444_CR74","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1007\/s10072-025-08221-8","volume":"46","author":"AS Badran","year":"2025","unstructured":"Badran AS, Khelifa H, Gbreel MI (2025) Exploring the role of melatonin in managing sleep and motor symptoms in Parkinson\u2019s disease: a pooled analysis of double-blinded randomized controlled trials. Neurol Sci 46:4155\u20134168. https:\/\/doi.org\/10.1007\/s10072-025-08221-8","journal-title":"Neurol Sci"},{"key":"1444_CR75","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.1007\/s10072-022-06111-x","volume":"43","author":"C Liguori","year":"2022","unstructured":"Liguori C, Fernandes M, Cerroni R et al (2022) Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson\u2019s disease: a preliminary evidence. Neurol Sci 43:5355\u20135362. https:\/\/doi.org\/10.1007\/s10072-022-06111-x","journal-title":"Neurol Sci"},{"key":"1444_CR76","first-page":"61","volume":"16","author":"N Adi","year":"2010","unstructured":"Adi N, Mash DC, Ali Y et al (2010) Melatonin MT1 and MT2 receptor expression in Parkinson\u2019s disease. Med Sci Monit 16:61\u201367","journal-title":"Med Sci Monit"},{"key":"1444_CR77","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF02257677","volume":"5","author":"E Fertl","year":"1993","unstructured":"Fertl E, Auff E, Doppelbauer A, Waldhauser F (1993) Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa. J Neural Transm Park Dis Dement Sect 5:227\u2013234. https:\/\/doi.org\/10.1007\/BF02257677","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"1444_CR78","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","volume":"71","author":"A Videnovic","year":"2014","unstructured":"Videnovic A, Noble C, Reid KJ et al (2014) Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol 71:463\u2013469. https:\/\/doi.org\/10.1001\/jamaneurol.2013.6239","journal-title":"JAMA Neurol"},{"key":"1444_CR79","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1600-079X.2006.00410.x","volume":"42","author":"K Satomura","year":"2007","unstructured":"Satomura K, Tobiume S, Tokuyama R et al (2007) Melatonin at pharmacological doses enhances human osteoblastic differentiation in vitro and promotes mouse cortical bone formation in vivo. J Pineal Res 42:231\u2013239. https:\/\/doi.org\/10.1111\/j.1600-079X.2006.00410.x","journal-title":"J Pineal Res"},{"key":"1444_CR80","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2174\/1389557511313030006","volume":"13","author":"RJ Reiter","year":"2013","unstructured":"Reiter RJ, Tan D-X, Rosales-Corral S, Manchester LC (2013) The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem 13:373\u2013384. https:\/\/doi.org\/10.2174\/1389557511313030006","journal-title":"Mini Rev Med Chem"},{"key":"1444_CR81","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/15376516.2019.1701595","volume":"30","author":"L Knani","year":"2020","unstructured":"Knani L, Venditti M, Kechiche S et al (2020) Melatonin protects bone against cadmium-induced toxicity via activation of Wnt\/\u03b2-catenin signaling pathway. Toxicol Mech Methods 30:237\u2013245. https:\/\/doi.org\/10.1080\/15376516.2019.1701595","journal-title":"Toxicol Mech Methods"},{"key":"1444_CR82","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1006\/exnr.1998.6848","volume":"152","author":"D Kirik","year":"1998","unstructured":"Kirik D, Rosenblad C, Bj\u00f6rklund A (1998) Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152:259\u2013277. https:\/\/doi.org\/10.1006\/exnr.1998.6848","journal-title":"Exp Neurol"},{"key":"1444_CR83","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1460-9568.2006.05285.x","volume":"25","author":"F Blandini","year":"2007","unstructured":"Blandini F, Levandis G, Bazzini E et al (2007) Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci 25:397\u2013405. https:\/\/doi.org\/10.1111\/j.1460-9568.2006.05285.x","journal-title":"Eur J Neurosci"},{"key":"1444_CR84","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/s0024-3205(99)80008-3","volume":"63","author":"A Hamdi","year":"1998","unstructured":"Hamdi A (1998) Melatonin administration increases the affinity of D2 dopamine receptors in the rat striatum. Life Sci 63:2115\u20132120. https:\/\/doi.org\/10.1016\/s0024-3205(99)80008-3","journal-title":"Life Sci"},{"key":"1444_CR85","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1023\/A:1015187601628","volume":"21","author":"N Zisapel","year":"2001","unstructured":"Zisapel N (2001) Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol 21:605\u2013616. https:\/\/doi.org\/10.1023\/A:1015187601628","journal-title":"Cell Mol Neurobiol"},{"key":"1444_CR86","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejphar.2008.07.022","volume":"594","author":"C Capitelli","year":"2008","unstructured":"Capitelli C, Sereniki A, Lima MMS et al (2008) Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats. Eur J Pharmacol 594:101\u2013108. https:\/\/doi.org\/10.1016\/j.ejphar.2008.07.022","journal-title":"Eur J Pharmacol"},{"key":"1444_CR87","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.parkreldis.2008.07.008","volume":"15","author":"J Ma","year":"2009","unstructured":"Ma J, Shaw VE, Mitrofanis J (2009) Does melatonin help save dopaminergic cells in MPTP-treated mice? Parkinsonism Relat Disord 15:307\u2013314. https:\/\/doi.org\/10.1016\/j.parkreldis.2008.07.008","journal-title":"Parkinsonism Relat Disord"},{"key":"1444_CR88","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/jnr.22201","volume":"88","author":"V Tapias","year":"2010","unstructured":"Tapias V, Cannon JR, Greenamyre JT (2010) Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson\u2019s disease model. J Neurosci Res 88:420\u2013427. https:\/\/doi.org\/10.1002\/jnr.22201","journal-title":"J Neurosci Res"},{"key":"1444_CR89","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF03033256","volume":"1","author":"CJ van der Schyf","year":"2000","unstructured":"van der Schyf CJ, Castagnoli K, Palmer S et al (2000) Melatonin fails to protect against long-term MPTP-induced dopamine depletion in mouse striatum. Neurotox Res 1:261\u2013269. https:\/\/doi.org\/10.1007\/BF03033256","journal-title":"Neurotox Res"},{"key":"1444_CR90","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3472032","volume":"2016","author":"JM Mack","year":"2016","unstructured":"Mack JM, Schamne MG, Sampaio TB et al (2016) Melatoninergic system in Parkinson\u2019s disease: from neuroprotection to the management of motor and nonmotor symptoms. Oxid Med Cell Longev 2016:3472032. https:\/\/doi.org\/10.1155\/2016\/3472032","journal-title":"Oxid Med Cell Longev"},{"key":"1444_CR91","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3109\/10715762.2015.1027198","volume":"49","author":"O Ozsoy","year":"2015","unstructured":"Ozsoy O, Yildirim FB, Ogut E et al (2015) Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model. Free Radic Res 49:1004\u20131014. https:\/\/doi.org\/10.3109\/10715762.2015.1027198","journal-title":"Free Radic Res"},{"key":"1444_CR92","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2106\/JBJS.20.00989","volume":"103","author":"JS Kimball","year":"2021","unstructured":"Kimball JS, Johnson JP, Carlson DA (2021) Oxidative stress and osteoporosis. J Bone Joint Surg Am 103:1451\u20131461. https:\/\/doi.org\/10.2106\/JBJS.20.00989","journal-title":"J Bone Joint Surg Am"},{"key":"1444_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043772","volume":"24","author":"T Iantomasi","year":"2023","unstructured":"Iantomasi T, Romagnoli C, Palmini G et al (2023) Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs. Int J Mol Sci 24:3772. https:\/\/doi.org\/10.3390\/ijms24043772","journal-title":"Int J Mol Sci"},{"key":"1444_CR94","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-6-2","volume":"6","author":"AI Bernstein","year":"2011","unstructured":"Bernstein AI, Garrison SP, Zambetti GP, O\u2019Malley KL (2011) 6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death. Mol Neurodegener 6:2. https:\/\/doi.org\/10.1186\/1750-1326-6-2","journal-title":"Mol Neurodegener"},{"key":"1444_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00480","volume":"10","author":"DP Cardinali","year":"2019","unstructured":"Cardinali DP (2019) Melatonin: clinical perspectives in neurodegeneration. Front Endocrinol (Lausanne) 10:480. https:\/\/doi.org\/10.3389\/fendo.2019.00480","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1444_CR96","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.2147\/JIR.S334423","volume":"14","author":"M Ikram","year":"2021","unstructured":"Ikram M, Park HY, Ali T, Kim MO (2021) Melatonin as a potential regulator of oxidative stress, and neuroinflammation: mechanisms and implications for the management of brain injury-induced neurodegeneration. J Inflamm Res 14:6251\u20136264. https:\/\/doi.org\/10.2147\/JIR.S334423","journal-title":"J Inflamm Res"},{"key":"1444_CR97","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.neuroscience.2006.10.004","volume":"144","author":"MP Smith","year":"2007","unstructured":"Smith MP, Cass WA (2007) Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson\u2019s disease. Neuroscience 144:1057\u20131066. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.10.004","journal-title":"Neuroscience"},{"key":"1444_CR98","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.devcel.2014.03.013","volume":"29","author":"T Mizoguchi","year":"2014","unstructured":"Mizoguchi T, Pinho S, Ahmed J et al (2014) Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development. Dev Cell 29:340\u2013349. https:\/\/doi.org\/10.1016\/j.devcel.2014.03.013","journal-title":"Dev Cell"},{"key":"1444_CR99","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/cdd.2015.168","volume":"23","author":"Q Chen","year":"2016","unstructured":"Chen Q, Shou P, Zheng C et al (2016) Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ 23:1128\u20131139. https:\/\/doi.org\/10.1038\/cdd.2015.168","journal-title":"Cell Death Differ"},{"key":"1444_CR100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00003086-197110000-00021","volume":"80","author":"P Meunier","year":"1971","unstructured":"Meunier P, Aaron J, Edouard C, Vignon G (1971) Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 80:147\u2013154. https:\/\/doi.org\/10.1097\/00003086-197110000-00021","journal-title":"Clin Orthop Relat Res"},{"key":"1444_CR101","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13287-019-1529-x","volume":"11","author":"C-X Wang","year":"2020","unstructured":"Wang C-X, Ge X-Y, Wang M-Y et al (2020) Dopamine D1 receptor-mediated activation of the ERK signaling pathway is involved in the osteogenic differentiation of bone mesenchymal stem cells. Stem Cell Res Ther 11:12. https:\/\/doi.org\/10.1186\/s13287-019-1529-x","journal-title":"Stem Cell Res Ther"},{"key":"1444_CR102","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s13287-023-03454-w","volume":"14","author":"G-Q Liu","year":"2023","unstructured":"Liu G-Q, Liu Z-X, Lin Z-X et al (2023) Effects of dopamine on stem cells and its potential roles in the treatment of inflammatory disorders: a narrative review. Stem Cell Res Ther 14:230. https:\/\/doi.org\/10.1186\/s13287-023-03454-w","journal-title":"Stem Cell Res Ther"},{"key":"1444_CR103","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ceca.2014.07.013","volume":"56","author":"L Zhang","year":"2014","unstructured":"Zhang L, Liu L, Thompson R, Chan C (2014) CREB modulates calcium signaling in cAMP-induced bone marrow stromal cells (BMSCs). Cell Calcium 56:257\u2013268. https:\/\/doi.org\/10.1016\/j.ceca.2014.07.013","journal-title":"Cell Calcium"},{"key":"1444_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112932","volume":"141","author":"Z-S Tao","year":"2024","unstructured":"Tao Z-S, Hu X-F, Sun T (2024) Melatonin prevents bone loss in osteoporotic rats with valproic acid treatment by anti-inflammatory and anti-oxidative stress. Int Immunopharmacol 141:112932. https:\/\/doi.org\/10.1016\/j.intimp.2024.112932","journal-title":"Int Immunopharmacol"},{"key":"1444_CR105","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12011-019-01893-2","volume":"196","author":"Z Cao","year":"2020","unstructured":"Cao Z, Geng X, Jiang X et al (2020) Melatonin attenuates AlCl3-induced apoptosis and osteoblastic differentiation suppression by inhibiting oxidative stress in MC3T3-E1 cells. Biol Trace Elem Res 196:214\u2013222. https:\/\/doi.org\/10.1007\/s12011-019-01893-2","journal-title":"Biol Trace Elem Res"},{"key":"1444_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12597","volume":"67","author":"L Knani","year":"2019","unstructured":"Knani L, Bartolini D, Kechiche S et al (2019) Melatonin prevents cadmium-induced bone damage: first evidence on an improved osteogenic\/adipogenic differentiation balance of mesenchymal stem cells as underlying mechanism. J Pineal Res 67:e12597. https:\/\/doi.org\/10.1111\/jpi.12597","journal-title":"J Pineal Res"},{"key":"1444_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.826660","volume":"13","author":"S Zheng","year":"2022","unstructured":"Zheng S, Zhou C, Yang H et al (2022) Melatonin accelerates osteoporotic bone defect repair by promoting osteogenesis-angiogenesis coupling. Front Endocrinol (Lausanne) 13:826660. https:\/\/doi.org\/10.3389\/fendo.2022.826660","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1444_CR108","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001779","volume":"8","author":"GS Taylor","year":"2020","unstructured":"Taylor GS, Moser O, Smith K et al (2020) Bone turnover and metabolite responses to exercise in people with and without long-duration type 1 diabetes: a case-control study. BMJ Open Diabetes Res Care 8:e001779. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001779","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1444_CR109","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2147\/CIA.S170111","volume":"13","author":"OA Mederle","year":"2018","unstructured":"Mederle OA, Balas M, Ioanoviciu SD et al (2018) Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis. Clin Interv Aging 13:1383\u20131389. https:\/\/doi.org\/10.2147\/CIA.S170111","journal-title":"Clin Interv Aging"},{"key":"1444_CR110","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3109\/10715762.2010.512040","volume":"45","author":"S Grimm","year":"2011","unstructured":"Grimm S, Hoehn A, Davies KJ, Grune T (2011) Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease. Free Radic Res 45:73\u201388. https:\/\/doi.org\/10.3109\/10715762.2010.512040","journal-title":"Free Radic Res"},{"key":"1444_CR111","doi-asserted-by":"publisher","first-page":"27298","DOI":"10.1074\/jbc.M702811200","volume":"282","author":"M Almeida","year":"2007","unstructured":"Almeida M, Han L, Martin-Millan M et al (2007) Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem 282:27298\u201327305. https:\/\/doi.org\/10.1074\/jbc.M702811200","journal-title":"J Biol Chem"},{"key":"1444_CR112","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1210\/er.2009-0024","volume":"31","author":"SC Manolagas","year":"2010","unstructured":"Manolagas SC (2010) From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 31:266\u2013300. https:\/\/doi.org\/10.1210\/er.2009-0024","journal-title":"Endocr Rev"},{"key":"1444_CR113","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.taap.2018.12.003","volume":"363","author":"SJ Ali","year":"2019","unstructured":"Ali SJ, Ellur G, Khan MT, Sharan K (2019) Bone loss in MPTP mouse model of Parkinson\u2019s disease is triggered by decreased osteoblastogenesis and increased osteoclastogenesis. Toxicol Appl Pharmacol 363:154\u2013163. https:\/\/doi.org\/10.1016\/j.taap.2018.12.003","journal-title":"Toxicol Appl Pharmacol"},{"key":"1444_CR114","doi-asserted-by":"publisher","first-page":"15020","DOI":"10.1038\/boneres.2015.20","volume":"3","author":"DJ Lee","year":"2015","unstructured":"Lee DJ, Tseng HC, Wong SW et al (2015) Dopaminergic effects on in vitro osteogenesis. Bone Res 3:15020. https:\/\/doi.org\/10.1038\/boneres.2015.20","journal-title":"Bone Res"},{"key":"1444_CR115","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s40001-024-01918-0","volume":"29","author":"H Shi","year":"2024","unstructured":"Shi H, Chen M (2024) The brain-bone axis: unraveling the complex interplay between the central nervous system and skeletal metabolism. Eur J Med Res 29:317. https:\/\/doi.org\/10.1186\/s40001-024-01918-0","journal-title":"Eur J Med Res"},{"key":"1444_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2013.04.019","volume":"56","author":"K Hanami","year":"2013","unstructured":"Hanami K, Nakano K, Saito K et al (2013) Dopamine D2-like receptor signaling suppresses human osteoclastogenesis. Bone 56:1\u20138. https:\/\/doi.org\/10.1016\/j.bone.2013.04.019","journal-title":"Bone"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01444-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-025-01444-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01444-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:20:45Z","timestamp":1766755245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-025-01444-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1007\/s00223-025-01444-z","relation":{},"ISSN":["1432-0827"],"issn-type":[{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental procedures were carried out in accordance with the rules of the ethics committee for research in the life sciences and health (CER-SVS) of the Higher Institute of Biotechnology of Monastir (ISBM). All the experiments were carried out in the animal facility of the ISBM. Animals were housed according to the EU directive 2010\/63\/EU regulating the welfare of experimental animals, under reference number EEA B-35-040 CER-VS\/ISBM022\/202.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}],"article-number":"135"}}